Reading the Evidence
Reading paths: learn to read medical evidence, in order
New to reading medical research? These curated reading paths sequence the evidence-appraisal writing of Dr. Damon Tojjar into short, ordered syllabi. Start with how to read a clinical trial, a risk or benefit number, a screening claim, or a clinical AI tool, then follow the steps in order or dip into any one on its own.
Choose a reading path
How to read a clinical study
A step-by-step path through the ideas you need to judge almost any treatment study: where it sits in the evidence, how it guards against bias, and how to read what it found.
7 stepsHow to read a risk or benefit number
Almost every health headline is a number about risk. This path is the toolkit for reading those numbers without being misled by the framing.
7 stepsHow to judge a clinical AI tool
A path for reading the evidence behind a medical algorithm the way you would read a drug trial: what it was tested on, whether it holds up elsewhere, and how people actually use it.
5 stepsHow to read a screening claim
Screening sounds like an unqualified good, yet it is where evidence literacy matters most. This path shows how a screening test earns its recommendation, and where it can mislead.
9 stepsHow to Appraise a Diagnostic or Screening Test
Every diagnostic or screening test arrives wrapped in numbers, and those numbers rarely mean what the headline implies. This path walks you through the accuracy figures, the way prevalence reshapes a result, and the particular traps that make screening look better than it is. By the end you will be able to read a test's claims, ask who was actually studied, and judge for yourself when finding disease early genuinely helps.
10 stepsHow to Read a Drug Trial
By the end of this path you will be able to follow a medicine from its earliest testing all the way to approval, and read each stage the way a careful appraiser does. You will know what a protocol fixes in advance, how doses and endpoints are chosen, how benefit and harm are weighed, and what a regulator actually requires before a drug reaches the pharmacy.
8 stepsReading Statistics and Uncertainty in Medical Evidence
Statistics can feel like a wall built to keep you out, but a handful of ideas do most of the real work. This path walks you through what a p-value, a confidence interval, and an effect size actually mean, and why a result can be statistically significant without mattering to a patient. By the end you will be able to read the numbers in a study with a steady eye, and see honest uncertainty as a mark of careful work rather than a weakness.
9 stepsHow Evidence Gets Synthesized
A single study rarely settles a question, so researchers gather many of them into one pooled answer. This path walks you through that process step by step, from where synthesis sits in the evidence hierarchy to systematic reviews, forest plots, publication bias, and the GRADE ratings that sit behind guidelines. By the end you will be able to open a systematic review and judge for yourself how much weight its bottom line can carry.
8 stepsReading Health News Without Being Misled
Health stories reach you through a chain of choices, from the study to the press release to the headline, and each link can bend the meaning. This path walks you through that chain so you can tell a solid finding from a dressed-up one, and read the next scary or hopeful headline with a calm, checking eye.
9 stepsHow to Read an Observational Study
Most medical questions can never be settled by a randomized trial, so much of what we know rests on observational studies that simply watch what happens to people over time. This path walks you through the ways those studies can mislead, from confounding and selection bias to the quiet traps of time and interpretation, and the methods researchers use to get closer to cause. By the end you will be able to read an observational finding and judge for yourself how much of it to believe.
10 stepsHow Clinical AI Earns Trust
Clinical AI is not trustworthy because it is accurate on a leaderboard; it earns trust the way a medicine does, through validation, honest reporting, and careful watching after launch. This path walks you through what separates a tool that deserves a place in care from one that only looks impressive. By the end you will be able to ask a clinical AI the right questions and read its evidence without being swayed by the marketing around it.
9 stepsHow Regulation Decides What Reaches Patients
Every drug and device a patient uses had to clear a regulator first, and those rules are not arbitrary. This path walks you through how evidence standards, market pathways, and post-market checks fit together, so you can tell what a clearance or an approval actually promises. By the end you will be able to look at a regulatory label and know what kind of evidence stands behind it.
9 stepsReading the Evidence in Diabetes, From Genes to Therapies
Modern diabetes care runs on a long chain of evidence, from the genes that set a person's risk to the trials behind a new drug. This path walks that chain in order, one real article at a time, so you can follow how a finding in the lab becomes a therapy in the clinic. By the end you will be able to read a diabetes claim and see where in that chain it sits and how much weight it can honestly bear.
9 stepsReading Prevention and Personal Risk
Prevention decisions turn on numbers that are easy to misread: how much a treatment lowers your risk, how many people have to take it for one to benefit, and where your own risk sits to begin with. This path walks you through those numbers in order, so you can read a prevention claim the way a careful clinician reads it and take part in the decision as an equal. By the end you will know why the same result can sound alarming or trivial, and what to ask before starting something meant to keep you well.
10 stepsHow a Lab Discovery Becomes a Treatment
Most promising discoveries never reach a single patient, and this path walks you through the reasons why. You will follow a finding from the lab bench through target selection, preclinical testing, first-in-human trials, and manufacturing all the way to routine care. By the end you will be able to read any translational claim and judge honestly where it sits on that long road.
9 stepsHow to Read an Oncology Trial
Cancer studies speak their own language: response rates, progression-free survival, hazard ratios, and biomarkers that decide who a drug is even meant for. This path walks you through that vocabulary in the order it matters, so you can open an oncology trial and tell a real survival benefit from a shrinking tumor that may not change how long someone lives. By the end you will read cancer evidence the way an appraiser does, asking what was measured and whether it counts.
9 stepsHow to Read Brain and Nervous System Evidence
Brain and nervous system evidence leans on things that are hard to pin down: a diagnosis assembled from criteria, an image read for subtle change, a symptom scored on a scale. This path walks you through real appraisals so you can tell what a neurologic test, scan, or trial endpoint actually establishes. By the end you will be able to read a brain study and see clearly where its certainty ends.
9 stepsReading the Evidence in Women's Health
Much of medicine was studied first in men, and that history still shapes how trials, drug doses, and screening advice reach women today. This path walks you through real appraisals so you can spot when a study population may not fit the patient, tell a treatment claim from a prevention claim, and read risk numbers in reproductive and menopausal care without being swayed by the framing. By the end you will read women's health evidence with a clearer eye for what it does and does not establish.
9 stepsReading the Evidence in Depression and Psychiatry
Psychiatric claims arrive wrapped in strong feelings and stronger headlines, from serotonin to psychedelics. This path teaches you to read the actual evidence behind depression care: what a symptom score means, how treatments are compared, and how to tell a robust finding from a hyped one. It is for curious readers and patients who want to weigh mental-health research on its merits.
9 stepsReading Cancer Screening and Early Detection
Screening promises to catch cancer early, but every test also finds disease that would never have caused harm. This path builds the core screening tradeoff, then walks through how breast, colorectal, lung, and prostate guidelines apply it, and how to judge new blood tests and whole-body scans. It is for readers who want to make sense of a screening recommendation instead of reacting to the word cancer.
10 stepsReading a Scan and Its Report
A radiology report can feel like a foreign language of doses, contrast agents, and structured scores. This path explains when imaging is appropriate, how to weigh radiation and contrast risks, how reporting systems turn a finding into a plan, and how to judge the AI now reading scans. It is for patients and readers who want to understand what a scan can and cannot tell them.
10 stepsAppraising a Clinical Prediction Model
Risk scores and clinical AI tools live or die on a handful of ideas that rarely make it into the marketing. This path builds them in order: overfitting, discrimination, calibration, the decision threshold, net benefit, external validation, and drift. It is for readers who want to judge whether a prediction model is trustworthy rather than merely impressive.
10 stepsReading Cancer Evidence, From Screening to Survival
This path walks you through how oncology evidence is made and judged, moving from the promise and peril of screening to how tumors are staged, how response is measured, and how survival is reported. It is for readers who want to interpret cancer studies and headlines without being misled by early detection or biomarker hype.
10 stepsReading the Evidence in Lung and Breathing Disease
This path teaches you to read respiratory evidence from the spirometry report up, covering how airflow is measured, how COPD and asthma are told apart, and how trials settle which treatments actually help. It suits readers who want to understand lung-function numbers and appraise the studies behind inhalers, oxygen, and biologics.
10 stepsReading Mental-Health Evidence With a Clear Eye
This path builds the skills to interpret psychiatry and psychology evidence, from what a symptom questionnaire really measures to how antidepressant trials handle placebo, effect size, and comparison. It is for readers who want to judge claims about depression and anxiety treatments fairly, without either dismissing or overselling them.
10 stepsReading Medical Imaging and Radiology Evidence
This path shows how imaging decisions are justified, from which scan the evidence supports to how radiation risk, incidental findings, and structured reporting are handled. It is for readers who want to understand a radiology report and appraise the studies behind screening scans and imaging AI.
Every step is a full article on the Reading the Evidence blog. Prefer definitions? See the glossary of evidence-appraisal terms.